NCT06556953Completed
Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients
Development and Validation of Machine Learning Models to Evaluate the Postoperative Venous Thromboembolism Risk of Cervical Cancer Patients in China
Source: ClinicalTrials.gov · Last updated 16 Aug 2024
Brief summary (registry, in English)
The aim of this study is to develop a machine learning model to accurately predict the risk of venous thromboembolism in patients with cervical cancer after surgery.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1174 (actual)
- First submitted
- 6 Aug 2024
- Start date
- 1 Jan 2019
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Haike Lei
- Diseases
- Cervical cancer
- NCT number
- NCT06556953
What you commit to
- Study type: Observational
- Participants enrolled: 1174
- From 1 Jan 2019 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of VTE caused by other reasons before surgery.
- Secondary cervical cancer or accompanying primary malignant tumor.
Age
- Patients under the age of 18.
Who the study is looking for
- Confirmation of cervical cancer through pathological examination.
- Receipt of surgical treatment for cervical cancer at Chongqing University Cancer Hospital in China.
- Provision of comprehensive case information.
Age in the registry: 20 years to 89 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chongqing University Cancer Hospital Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.